Concepedia

Aparna Lakshmanan

AL

Statistics

Publications

5

Citations

132

H-Index

5

Active since

2011

Affiliations

The Ohio State University(Current)

Inserm

Centre de Recherche en Cancérologie de Lyon

Aparna Lakshmanan is an author at The Ohio State University specializing in oncology, radioiodine therapy, and thyroid cancer.

Publications per year

2011–2023

5

Publications

5

microRNA-339-5p modulates Na+/I− symporter-mediated radioiodide uptake

Aparna Lakshmanan, Anna Wójcicka, Marta Kotlarek et al. · Endocrine Related Cancer · 2014 · 42 citations · Full text

, , +17

Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin

Aparna Lakshmanan, Daniel Scarberry, Jill A. Green et al. · Oncotarget · 2015 · 34 citations · Full text

, , +16

KT5823 Differentially Modulates Sodium Iodide Symporter Expression, Activity, and Glycosylation between Thyroid and Breast Cancer Cells

Sasha Beyer, Aparna Lakshmanan, Xiaoli Zhang et al. · Endocrinology · 2011 · 24 citations · Full text

, , +15

Apigenin in Combination with Akt Inhibition Significantly Enhances Thyrotropin-Stimulated Radioiodide Accumulation in Thyroid Cells

Aparna Lakshmanan, Andrea I. Doseff, Matthew D. Ringel et al. · Thyroid · 2014 · 18 citations · Full text

, , +13

Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer

Fátima Cardoso, William Jacot, Sherko Küemmel et al. · Cancer Research · 2023 · 14 citations

, , +15

1–5 of 5